Market Risers: BHP Billiton plc, GlaxoSmithKline plc, Glencore plc, Kingfisher plc

BHP Billiton
[shareaholic app="share_buttons" id_name="post_below_content"]

Shares of BHP Billiton plc with company EPIC: LON:BLT has risen 2.41% or 34.6 points in today’s trading session so far. Traders have remained optimistic while the stock has been in play. Range high for the period so far is 1477.6 and a low of 1453. The number of shares traded by this point in time totalled 3,742,909 with the average number of shares traded daily being 8,764,674. The 52 week high is 1662.4 about 225.4 points in difference on the previous days close and a 52 week low being 1103 is a variance of 334 points. BHP Billiton plc has a 20 day moving average of 1529.73 and now a 50 day moving average of 1563.18. The market capitalisation is now £84,642.96m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for BHP Billiton plc being recorded at Tuesday, March 6, 2018 at 12:14:18 PM GMT with the stock price trading at 1471.6 GBX.

 

 

Stock in GlaxoSmithKline plc ticker lookup code: LON:GSK has stepped up 1.16% or 15.2 points during today’s session so far. Market buyers have remained positive during the session. The high for the period has peaked at 1334 meanwhile the session low reached 1318. The total volume of shares traded by this point was 2,518,717 with the average number of shares traded daily being 8,894,165. The 52 week high for the shares is 1724.5 which is 415.7 points difference from the previous close and the 52 week low at 1235.2 making a difference of 73.59 points.
GlaxoSmithKline plc has a 20 day moving average of 1309 and also a 50 day moving average at 1331.63. This puts the market capitalisation now at £65,655.39m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for GlaxoSmithKline plc being recorded at Tuesday, March 6, 2018 at 12:14:18 PM GMT with the stock price trading at 1324 GBX.

 

 

The trading price for Glencore plc found using EPIC: LON:GLEN has gained 1.73% or 6.3 points during today’s session so far. Market buyers have stayed positive while the stock has been in play. The period high was 372.25 and hitting a low of 366.2. Volume total for shares traded at this point reached 18,299,627 whilst the daily average number of shares exchanged is just 42,141,278. The 52 week high is 416.91 some 52.11 points in difference on the previous days close and a 52 week low being 270 which is a variance of 94.8 points. Glencore now has a 20 SMA of 388.82 and now its 50 day SMA of 396.7. This puts the market capitalisation now at £53,352.90m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Glencore being recorded at Tuesday, March 6, 2018 at 12:14:06 PM GMT with the stock price trading at 371.1 GBX.

 

 

Stock in Kingfisher plc with company EPIC: LON:KGF has moved up 1.09% or 3.8 points in today’s trading session so far. Buyers have stayed positive during this period. Range high for the period so far is 353.2 and a low of 347.1. The amount of shares exchanged has so far reached 1,470,795 with the daily average traded share volume around 9,621,355. The 52 week high price for the shares is 369.8 which comes in at 22.7 points in difference to the previous days close of business and a 52 week low sitting at 285.3 making a difference of 61.8 points. Kingfisher plc now has a 20 moving average of 357.93 and now the 50 day simple moving average now of 351.51. The current market capitalisation is £7,582.78m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for Kingfisher plc being recorded at Tuesday, March 6, 2018 at 12:14:30 PM GMT with the stock price trading at 350.9 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    GSK's Arexvy vaccine receives approval in Japan to protect adults aged 50-59 at increased risk from severe RSV infection, expanding its coverage.
    GSK Plc reports Q3 2024 results with strong growth in Specialty Medicines offsetting lower Vaccine sales. Core earnings rose by 5%, despite Zantac charges.
    GSK's new antibiotic gepotidacin earns FDA's Priority Review, marking potential first new uUTI oral treatment in 20 years, with decision due March 2025.

      Search

      Search